Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus
出版年份 2014 全文链接
标题
Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus
作者
关键词
Biomarkers, End-stage renal disease, Mortality, Type 2 diabetes
出版物
DIABETOLOGIA
Volume 58, Issue 1, Pages 188-198
出版商
Springer Nature
发表日期
2014-10-14
DOI
10.1007/s00125-014-3389-3
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Association of Urinary Injury Biomarkers with Mortality and Cardiovascular Events
- (2014) M. J. Sarnak et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with mortality in a community-based cohort of older Swedish men
- (2013) Johanna Helmersson-Karlqvist et al. ATHEROSCLEROSIS
- The Modern Spectrum of Renal Biopsy Findings in Patients with Diabetes
- (2013) S. G. Sharma et al. Clinical Journal of the American Society of Nephrology
- Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes
- (2013) E. Jennifer Weil et al. DIABETES
- Urinary Liver-Type Fatty Acid-Binding Protein and Progression of Diabetic Nephropathy in Type 1 Diabetes
- (2013) N. M. Panduru et al. DIABETES CARE
- High Serum N-Acetyl-ß-D-Glucosaminidase Activity Is a Predictor of 28-Year Mortality in a Population of Community-Dwelling Japanese-The Tanushimaru Study
- (2013) Kuniko Yoshikawa et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Analysis of a Urinary Biomarker Panel for Incident Kidney Disease and Clinical Outcomes
- (2013) C. M. O'Seaghdha et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Urinary Biomarkers of AKI and Mortality 3 Years after Cardiac Surgery
- (2013) S. G. Coca et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Urine neutrophil gelatinase–associated lipocalin levels do not improve risk prediction of progressive chronic kidney disease
- (2013) Kathleen D. Liu et al. KIDNEY INTERNATIONAL
- Clinical Value of NGAL, L-FABP and Albuminuria in Predicting GFR Decline in Type 2 Diabetes Mellitus Patients
- (2013) Kuei-Mei Chou et al. PLoS One
- Testing for improvement in prediction model performance
- (2013) Margaret Sullivan Pepe et al. STATISTICS IN MEDICINE
- Interpreting Incremental Value of Markers Added to Risk Prediction Models
- (2012) Michael J. Pencina et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Predictive Effects of Urinary Liver-Type Fatty Acid-Binding Protein for Deteriorating Renal Function and Incidence of Cardiovascular Disease in Type 2 Diabetic Patients Without Advanced Nephropathy
- (2012) S.-i. Araki et al. DIABETES CARE
- Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients
- (2012) Sang Soo Kim et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Tubular markers are associated with decline in kidney function in proteinuric type 2 diabetic patients
- (2012) Stine E. Nielsen et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Measuring urinary tubular biomarkers in type 2 diabetes does not add prognostic value beyond established risk factors
- (2012) Bryan R. Conway et al. KIDNEY INTERNATIONAL
- The effect of RAAS blockade on markers of renal tubular damage in diabetic nephropathy: u-NGAL, u-KIM1 and u-LFABP
- (2012) Stine E. Nielsen et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Misuse of DeLong test to compare AUCs for nested models
- (2012) Olga V. Demler et al. STATISTICS IN MEDICINE
- Clinical Significance of Urinary Liver-Type Fatty Acid-Binding Protein in Diabetic Nephropathy of Type 2 Diabetic Patients
- (2011) A. Kamijo-Ikemori et al. DIABETES CARE
- Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration
- (2011) Wen-Jin Fu et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Kidney injury molecule-1 andN-acetyl-ß-d-glucosaminidase in chronic heart failure: possible biomarkers of cardiorenal syndrome
- (2011) Carsten G. Jungbauer et al. EUROPEAN JOURNAL OF HEART FAILURE
- Tubular biomarkers to assess progression of diabetic nephropathy
- (2011) Gianfranco Tramonti et al. KIDNEY INTERNATIONAL
- Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy
- (2011) Stine E. Nielsen et al. KIDNEY INTERNATIONAL
- Urinary Liver-Type Fatty Acid-Binding Protein Predicts Progression to Nephropathy in Type 1 Diabetic Patients
- (2010) S. E. Nielsen et al. DIABETES CARE
- Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril
- (2010) S. E. Nielsen et al. DIABETIC MEDICINE
- Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase
- (2010) Vishal S. Vaidya et al. KIDNEY INTERNATIONAL
- Urinary Neutrophil Gelatinase-Associated Lipocalin and Progression of Diabetic Nephropathy in Type 1 Diabetic Patients in a Four-Year Follow-Up Study
- (2010) Stine Elkjaer Nielsen et al. NEPHRON CLINICAL PRACTICE
- Urinary Biomarkers in the Early Detection of Acute Kidney Injury after Cardiac Surgery
- (2009) W. K. Han et al. Clinical Journal of the American Society of Nephrology
- Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Progression of Chronic Kidney Disease
- (2009) D. Bolignano et al. Clinical Journal of the American Society of Nephrology
- Urinary L-FABP and anaemia: distinct roles of urinary markers in type 2 diabetes
- (2009) M. von Eynatten et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Predictive Power of Sequential Measures of Albuminuria for Progression to ESRD or Death in Pima Indians With Type 2 Diabetes
- (2008) Meda E. Pavkov et al. AMERICAN JOURNAL OF KIDNEY DISEASES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started